马里兰全球预算收入与癌症手术医保支出的关联
该研究比较马里兰实施全球预算收入(GBR)前后4年,接受癌症导向手术的Medicare受益人与匹配对照州在支出、临床结局和急性护理利用上的变化。结果显示30天再入院率降低2.2个百分点(95%CI -4.3至-0.1),30天支出、死亡率和急诊就诊无显著变化,大手术亚组也无显著结果。
要点
- GBR实施4年内癌症手术30天再入院率降低2.2个百分点。
- 30天支出、死亡率和急诊就诊无显著变化。
- 大手术亚组分析未发现显著结果。
核心结论
- 全球预算收入与癌症导向手术后4年内的支出、急诊利用或临床结局变化无关,30天再入院率有适度下降。
研究设计与样本
- 研究采用双重差分分析,比较马里兰35家医院与24个对照州101家匹配医院。
- 比较GBR实施前(2011-2013)与实施后(2015-2018)的结局变化。
- 对常在住院环境进行的大手术(膀胱切除、食管切除、胃切除、结直肠切除、肾切除、胰腺切除和肺切除)进行亚组分析。
主要发现
- 马里兰患者30天再入院率降低2.2个百分点(95%CI -4.3至-0.1),差异有统计学意义。
- 30天支出、死亡率或急诊就诊无统计学显著变化。
- 大手术亚组分析未报告显著结果。
临床怎么用
- GBR模式未明显改变癌症手术的支出、急诊利用或临床结局,但再入院率略有下降。
- 针对专科的医疗质量定义及整个照护价值链(如医生激励)的对齐可能有助于改善高价值照护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: In 2014, Maryland initiated the global budget revenue (GBR) model, placing caps on total hospital expenditures across all care sites. The GBR program aims to reduce unnecessary utilization while maintaining or improving care quality. To date, there has been limited examination of program effects on cancer care. OBJECTIVE: To compare changes in spending, clinical outcomes, and acute care utilization through 4 years of the GBR program among Medicare beneficiaries who undergo cancer-directed surgery in Maryland vs matched control states. DESIGN, SETTING, AND PARTICIPANTS: Drawing from a matched pool of hospitals in Maryland (n = 35) and 24 control states with a similar timing of Medicaid expansion (n = 101), we identified Medicare beneficiaries from Maryland and control states who underwent any cancer-directed surgery from 2011 through 2018. Using difference-in-differences analysis, we compared changes in outcomes from before (2011-2013) to after (2015-2018) GBR implementation between patients treated in Maryland and control states. We also performed a subgroup analysis among patients who underwent major surgical procedures that are usually performed in the inpatient setting (cystectomy, esophagectomy, gastrectomy, colorectal resection, nephrectomy, pancreatectomy, and lung resection). MAIN OUTCOMES AND MEASURES: Thirty-day episode spending, mortality, readmissions, and emergency department (ED) visits. RESULTS: Relative to Medicare beneficiaries undergoing cancer surgery in control states (n = 4737; 3323 [70.1%] female; 571 [12.1%] dual-eligible; mean [SD] age 74.9 [6.5] years), patients in Maryland (n = 20 320; 14 068 [69.2%] female; 1705 [8.4%] dual-eligible; mean [SD] age 74.9 [6.5] years) had a statistically significant reduction of 2.2 percentage points (95% CI, -4.3 to -0.1) in the 30-day readmission rate. We found no statistically significant changes in 30-day spending, mortality, or ED visits. We report no significant results in the subgroup analysis of patients undergoing major surgical procedures. CONCLUSIONS AND RELEVANCE: Global budget revenue was not associated with changes in expenditures, ED utilization, or clinical outcomes after cancer-directed surgery through 4 years. There was a modest decline in 30-day readmissions. Specialty-specific definitions of care quality and better alignment across the entire care delivery value chain (ie, physician incentives) may be strategies that could improve delivery of high-value care for beneficiaries undergoing cancer surgery.
引用
- Offodile AC, Lin YL, Melamed A, et al. Association of Maryland Global Budget Revenue With Spending and Outcomes Related to Surgical Care for Medicare Beneficiaries With Cancer. JAMA Surg. 2022. PMID: 35385085. doi:10.1001/jamasurg.2022.0135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。